Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)

NSE:ARISTO Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	3,265	2,451	2,179	1,658	1,672	2,012
Other Revenue	0	0	-	-	-	-
Revenue	3,265	2,451	2,179	1,658	1,672	2,012
Revenue Growth (YoY)	47.30%	12.53%	31.43%	-0.87%	-16.90%	-0.22%
Cost of Revenue	3,015	2,260	1,960	1,472	1,502	1,877
Gross Profit	249.66	191.1	218.55	185.63	170.66	135.76
Selling, General & Admin	20.94	37.28	58.42	53.94	36.3	40.7
Other Operating Expenses	114.02	68.18	72.19	79.36	90.91	49.98
Operating Expenses	155.77	121.16	145.97	144.29	134.71	95.87
Operating Income	93.89	69.94	72.58	41.34	35.95	39.89
Interest Expense	-16.7	-16.68	-22.07	-18.82	-22.09	-21.44
Interest & Investment Income	0.46	0.46	0.56	0.24	0.12	0.08
Currency Exchange Gain (Loss)	0.8	0.8	-2.42	-0.1	2.06	-3.54
Other Non Operating Income (Expenses)	0.48	-0.45	-1.26	-2.42	-1.05	-1.03
EBT Excluding Unusual Items	78.93	54.08	47.39	20.25	14.98	13.96
Gain (Loss) on Sale of Assets	-0	-0	-	0.16	-	-
Asset Writedown	-	-	-	-0.6	-	-
Pretax Income	78.92	54.08	47.39	19.8	14.98	13.96
Income Tax Expense	20.16	15.12	11.77	5.47	4.22	3.89
Net Income	58.76	38.96	35.62	14.34	10.76	10.07
Net Income to Common	58.76	38.96	35.62	14.34	10.76	10.07
Net Income Growth	64.62%	9.36%	148.44%	33.29%	6.78%	-64.38%
Shares Outstanding (Basic)	7	7	5	5	5	5
Shares Outstanding (Diluted)	7	7	5	5	5	5
Shares Change (YoY)	9.66%	28.43%	6.13%	-	-	-
EPS (Basic)	8.63	5.72	6.72	2.87	2.15	2.02
EPS (Diluted)	8.63	5.72	6.72	2.87	2.15	2.02
EPS Growth	50.10%	-14.88%	134.14%	33.27%	6.78%	-64.38%
Free Cash Flow	27.17	10.45	-68.44	35.29	2.95	-7.93
Free Cash Flow Per Share	3.99	1.54	-12.91	7.07	0.59	-1.59
Dividend Per Share	-	0.400	0.250	-	-	-
Dividend Growth	-	60.00%	-	-	-	-
Gross Margin	7.65%	7.80%	10.03%	11.20%	10.21%	6.75%
Operating Margin	2.88%	2.85%	3.33%	2.49%	2.15%	1.98%
Profit Margin	1.80%	1.59%	1.64%	0.86%	0.64%	0.50%
Free Cash Flow Margin	0.83%	0.43%	-3.14%	2.13%	0.18%	-0.39%
EBITDA	114.71	85.65	87.95	52.33	43.44	45.08
EBITDA Margin	3.51%	3.49%	4.04%	3.16%	2.60%	2.24%
D&A For EBITDA	20.82	15.71	15.36	10.99	7.49	5.19
EBIT	93.89	69.94	72.58	41.34	35.95	39.89
EBIT Margin	2.88%	2.85%	3.33%	2.49%	2.15%	1.98%
Effective Tax Rate	25.55%	27.96%	24.83%	27.60%	28.20%	27.84%
Revenue as Reported	3,267	2,453	2,182	1,660	1,672	2,012
Advertising Expenses	-	0.3	0.25	0.04	0.04	2.25

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.